23,338,039
Vote Records
27,979
Companies
11,817
Funds
4,051
Managers

Home › Companies › GoodRx Holdings, Inc. › 2025-2026

GoodRx Holdings, Inc. 2025-2026 Proxy Voting Records

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings and GoodRx Holdings, Inc.’s Form 8-K, filed June 18, 2026 (Item 5.07 on EDGAR). Page generated November 20, 2026.

  • 5Ballot items
  • 133Asset managers, any item
  • 496Fund votes
  • June 16, 2026Meeting date

Results at a glance

Meeting of June 16, 2026: 5 items on GoodRx Holdings, Inc.’s Form 8-K, filed June 18, 2026: 5 passed (calculated).

Dissent

No notable dissent.

Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore GoodRx Holdings, Inc. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by GoodRx Holdings, Inc.

These tallies are GoodRx Holdings, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 18, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

GoodRx Holdings, Inc. — official shareholder meeting results, meeting held June 16, 2026
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Wendy Barnes 2,379,952,868---- 10,078,86039,543,093 99.6%Passed (calculated)—
Elect Director: Ronald E. Bruehlman 2,380,863,641---- 9,168,08739,543,093 99.6%Passed (calculated)—
Elect Director: Gregory Mondre 2,382,474,121---- 7,557,60739,543,093 99.7%Passed (calculated)—
2. Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 2,429,055,999335,716183,106 --0 99.9%Passed (calculated)—
3. Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers 2,363,913,37023,702,5202,415,838 --39,543,093 99.0%Passed (calculated)—

Source: GoodRx Holdings, Inc., Form 8-K, filed with the SEC on June 18, 2026 — read the filing on EDGAR.

How asset managers voted at the GoodRx Holdings, Inc. 2025-2026 meeting

133 asset managers disclosed a vote on at least one GoodRx Holdings, Inc. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.

Elect Director: Gregory Mondre

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 4 wordings of this item as funds reported it.

99.7% Majority: yes · of votes cast

FOR 99.7%
FOR: 2,382,474,121WITHHELD: 7,557,607
Details: description as filed, official tally, votes by 25 asset managers

Description as filed by funds: Election of Directors: Gregory Mondre

GoodRx Holdings, Inc.’s own tally for this item (“Elect Director: Gregory Mondre”): 2,382,474,121 for, 7,557,607 withheld, per its Form 8-K filed June 18, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.7% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 25 asset managers below reported 9,799,803 for, 697,952 withheld, 43,143 abstained.

FOR
FOR: 9,799,803ABSTAIN: 43,143WITHHOLD: 697,952
Largest asset managers voting on “Election of Directors: Gregory Mondre” at GoodRx Holdings, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard7,556,3260 378,748For
Pacer Funds Trust742,3620 00For
Charles Schwab562,0750 00For
SEI396,3000 00For
Invesco288,6580 00For
Northern Trust00 0256,892Withhold
WisdomTree00 0172,695Withhold
Dimensional00 0143,668Withhold
Fidelity102,0940 041,272Mixed
Harbor ETF Trust70,4030 00For
Legg Mason38,1140 00For
BlackRock00 37,8350Abstain
American Century00 029,169Withhold
Russell Investments27,4010 00For
State Street250 023,095Withhold
Goldman Sachs16,0450 00For
Prudential/PGIM00 012,470Withhold
Lincoln Financial00 08,959Withhold
Allianz00 3,0970Abstain
John Hancock00 2,0900Abstain
Advisors' Inner Circle Fund III00 0501Withhold
Blackstone Alternative Investment Funds00 0300Withhold
Victory Capital00 0103Withhold
Jackson National00 840Abstain
E Trade Trust00 080Withhold

Elect Director: Ronald E. Bruehlman

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 4 wordings of this item as funds reported it.

99.6% Majority: yes · of votes cast

FOR 99.6%
FOR: 2,380,863,641WITHHELD: 9,168,087
Details: description as filed, official tally, votes by 25 asset managers

Description as filed by funds: Election of Directors: Ronald E. Bruehlman

GoodRx Holdings, Inc.’s own tally for this item (“Elect Director: Ronald E. Bruehlman”): 2,380,863,641 for, 9,168,087 withheld, per its Form 8-K filed June 18, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.6% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 25 asset managers below reported 10,168,136 for, 367,465 withheld, 5,297 abstained.

FOR
FOR: 10,168,136ABSTAIN: 5,297WITHHOLD: 367,465
Largest asset managers voting on “Election of Directors: Ronald E. Bruehlman” at GoodRx Holdings, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard7,565,0850 260For
Pacer Funds Trust742,3620 00For
Charles Schwab562,0750 00For
SEI396,3000 00For
Invesco288,6580 00For
Northern Trust256,8920 00For
WisdomTree00 0172,695Withhold
Dimensional00 0143,668Withhold
Fidelity143,3660 00For
Harbor ETF Trust70,4030 00For
Legg Mason38,1140 00For
BlackRock37,8350 00For
American Century00 029,169Withhold
Russell Investments27,4010 00For
State Street23,0990 021For
Goldman Sachs16,0450 00For
Prudential/PGIM00 012,470Withhold
Lincoln Financial00 08,959Withhold
Allianz00 3,0970Abstain
John Hancock00 2,0900Abstain
Advisors' Inner Circle Fund III5010 00For
Blackstone Alternative Investment Funds00 0300Withhold
Victory Capital00 0103Withhold
Jackson National00 840Abstain
E Trade Trust00 080Withhold

Elect Director: Wendy Barnes

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 4 wordings of this item as funds reported it.

99.6% Majority: yes · of votes cast

FOR 99.6%
FOR: 2,379,952,868WITHHELD: 10,078,860
Details: description as filed, official tally, votes by 25 asset managers

Description as filed by funds: Election of Directors: Wendy Barnes

GoodRx Holdings, Inc.’s own tally for this item (“Elect Director: Wendy Barnes”): 2,379,952,868 for, 10,078,860 withheld, per its Form 8-K filed June 18, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.6% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 25 asset managers below reported 9,879,477 for, 656,123 withheld, 5,298 abstained.

FOR
FOR: 9,879,477ABSTAIN: 5,298WITHHOLD: 656,123
Largest asset managers voting on “Election of Directors: Wendy Barnes” at GoodRx Holdings, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard7,565,0840 270For
Pacer Funds Trust742,3620 00For
Charles Schwab562,0750 00For
SEI396,3000 00For
Invesco00 0288,658Withhold
Northern Trust256,8920 00For
WisdomTree00 0172,695Withhold
Dimensional00 0143,668Withhold
Fidelity143,3660 00For
Harbor ETF Trust70,4030 00For
Legg Mason38,1140 00For
BlackRock37,8350 00For
American Century00 029,169Withhold
Russell Investments27,4010 00For
State Street23,0990 021For
Goldman Sachs16,0450 00For
Prudential/PGIM00 012,470Withhold
Lincoln Financial00 08,959Withhold
Allianz00 3,0970Abstain
John Hancock00 2,0900Abstain
Advisors' Inner Circle Fund III5010 00For
Blackstone Alternative Investment Funds00 0300Withhold
Victory Capital00 0103Withhold
Jackson National00 840Abstain
E Trade Trust00 080Withhold

Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers

Calculated outcomeFund totals may overlapSECTION 14A SAY-ON-PAY VOTESPassed (calculated)

Combines 7 wordings of this item as funds reported it.

99.0% Majority: yes · of votes cast

FOR 99.0%
FOR: 2,363,913,370AGAINST: 23,702,520

Prior year: 99.9% for (June 3, 2025 meeting) ▼ 0.9 pts

Details: description as filed, official tally, votes by 133 asset managers

Description as filed by funds: APPROVAL, ON AN ADVISORY (NON-BINDING) BASIS, OF THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.

GoodRx Holdings, Inc.’s own tally for this item (“3. Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers”): 2,363,913,370 for, 23,702,520 against, per its Form 8-K filed June 18, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.0% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 25 asset managers voting on “APPROVAL, ON AN ADVISORY (NON-BINDING) BASIS, OF THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.” at GoodRx Holdings, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard4,196,5503,368,548 130Mixed
Pacer Funds Trust0742,362 00Against
Charles Schwab0562,075 00Against
SEI0396,300 00Against
Invesco0288,658 00Against
Northern Trust0256,892 00Against
WisdomTree0172,695 00Against
Dimensional0143,668 00Against
Fidelity0143,366 00Against
Harbor ETF Trust70,4030 00For
Legg Mason00 38,1140Abstain
BlackRock037,835 00Against
American Century29,1690 00For
Russell Investments027,401 00Against
State Street23,07743 00For
Goldman Sachs16,0450 00For
Prudential/PGIM012,470 00Against
Lincoln Financial08,959 00Against
Allianz03,097 00Against
John Hancock02,090 00Against
Advisors' Inner Circle Fund III0501 00Against
Blackstone Alternative Investment Funds0300 00Against
Victory Capital0103 00Against
Jackson National084 00Against
E Trade Trust080 00Against

Fund voting reports, all 25 managers: 4,335,244 for, 6,167,527 against, 38,127 abstained.

Institutional-manager reports: 121 asset managers voting on “APPROVAL, ON AN ADVISORY (NON-BINDING) BASIS, OF THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.” at GoodRx Holdings, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Silver Lake Group, L.L.C.129,527,6080 00For
Francisco Partners Management, LP60,078,1840 00For
Petrus Trust Company, LTA3,098,5590 00For
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.00 2,105,5020Abstain
LSV ASSET MANAGEMENT02,088,134 00Against
Technology Crossover Management X, Ltd.1,653,5660 00For
AMERIPRISE FINANCIAL INC01,439,024 00Against
BlackRock16,1481,224,032 00Against
AQR0952,893 00Against
Invesco0792,850 00Against
STIFEL NICOLAUS & CO INC \MO\0792,486 00Against
Vanguard665,94523,762 00For
Charles Schwab0563,299 00Against
Goldman Sachs468,6430 00For
SEI0397,064 00Against
Universal-Investment-Gesellschaft mbH0379,634 00Against
Victory Capital0350,717 00Against
MACKENZIE FINANCIAL CORP0348,989 00Against
MOORE CAPITAL MANAGEMENT, LP0300,838 00Against
UI BVK Kapitalverwaltungsgesellschaft mbH0286,300 00Against
Janney Montgomery Scott LLC0203,088 00Against
Evercore Wealth Management, LLC0184,834 00Against
Northern Trust0184,096 00Against
WELLS FARGO CLEARING SERVICES, LLC162,3010 00For
Renaissance0143,552 00Against

Institutional-manager reports, all 121 managers: 196,049,943 for, 11,834,646 against, 2,143,616 abstained, 5,029 not voted. Showing the 25 largest; every one is in the interactive database (link above).

Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the…

Calculated outcomeAUDIT-RELATEDPassed (calculated)

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 2,429,055,999AGAINST: 335,716

Prior year: 100.0% for (June 3, 2025 meeting) unchanged

Details: description as filed, official tally, votes by 25 asset managers

Description as filed by funds: RATIFICATION OF THE APPOINTMENT OF KPMG LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2026.

GoodRx Holdings, Inc.’s own tally for this item (“2. Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026”): 2,429,055,999 for, 335,716 against, per its Form 8-K filed June 18, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 25 asset managers below reported 10,540,897 for.

FOR
FOR: 10,540,897
Largest asset managers voting on “RATIFICATION OF THE APPOINTMENT OF KPMG LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR” at GoodRx Holdings, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard7,565,1100 00For
Pacer Funds Trust742,3620 00For
Charles Schwab562,0750 00For
SEI396,3000 00For
Invesco288,6580 00For
Northern Trust256,8920 00For
WisdomTree172,6950 00For
Dimensional143,6680 00For
Fidelity143,3660 00For
Harbor ETF Trust70,4030 00For
Legg Mason38,1140 00For
BlackRock37,8350 00For
American Century29,1690 00For
Russell Investments27,4010 00For
State Street23,1200 00For
Goldman Sachs16,0450 00For
Prudential/PGIM12,4700 00For
Lincoln Financial8,9590 00For
Allianz3,0970 00For
John Hancock2,0900 00For
Advisors' Inner Circle Fund III5010 00For
Blackstone Alternative Investment Funds3000 00For
Victory Capital1030 00For
Jackson National840 00For
E Trade Trust800 00For

Largest GoodRx Holdings, Inc. shareholders voting in 2025-2026

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 340,531,000 shares outstanding at the time of that meeting.

Fund voting reports: top GoodRx Holdings, Inc. shareholders by shares voted on “APPROVAL, ON AN ADVISORY (NON-BINDING) BASIS, OF THE COMPENSATION OF THE COMPANY'S NAMED…”, 2025-2026
#Asset manager % of shares outstanding
1Vanguard 2.22%
2Pacer Funds Trust 0.22%
3Charles Schwab 0.17%
4SEI 0.12%
5Invesco 0.08%
6Northern Trust 0.08%
7WisdomTree 0.05%
8Dimensional 0.04%
9Fidelity 0.04%
10Harbor ETF Trust 0.02%
Institutional-manager reports: top GoodRx Holdings, Inc. shareholders by shares voted on “APPROVAL, ON AN ADVISORY (NON-BINDING) BASIS, OF THE COMPENSATION OF THE COMPANY'S NAMED…”, 2025-2026
#Asset manager % of shares outstanding
1Silver Lake Group, L.L.C. 38.04%
2Francisco Partners Management, LP 17.64%
3Petrus Trust Company, LTA 0.91%
4PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. 0.62%
5LSV ASSET MANAGEMENT 0.61%
6Technology Crossover Management X, Ltd. 0.49%
7AMERIPRISE FINANCIAL INC 0.42%
8BlackRock 0.36%
9AQR 0.28%
10Invesco 0.23%

Reported GoodRx Holdings, Inc. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.

GoodRx Holdings, Inc. holdings and ownership disclosed for the 2025-2026 proxy season, with each row’s source and date
HolderShares % outstandingSource, as of
Francisco Partners GP IV, L.P.52,578,184 15.44%Schedule 13D, filed August 26, 2026
Vanguard Group9,584,183 2.81%Form 13F, quarter ended March 31, 2026
Renaissance Technologies3,259,738 0.96%Form 13F, quarter ended March 31, 2026
Dimensional Fund Advisors2,451,141 0.72%Form 13F, quarter ended March 31, 2026
BlackRock1,861,591 0.55%Form 13F, quarter ended March 31, 2026
AQR Capital1,802,345 0.53%Form 13F, quarter ended March 31, 2026
Morgan Stanley1,118,427 0.33%Form 13F, quarter ended March 31, 2026
Geode Capital1,078,127 0.32%Form 13F, quarter ended March 31, 2026
Goldman Sachs1,057,961 0.31%Form 13F, quarter ended March 31, 2026
State Street1,011,189 0.30%Form 13F, quarter ended March 31, 2026

Percentages above are of 340,531,000 shares outstanding, as reported by GoodRx Holdings, Inc. on its Form 10-Q dated March 31, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this meeting

At GoodRx Holdings, Inc.'s shareholder meeting held June 16, 2026, in the 2025-2026 proxy season, 133 asset managers reported votes on at least one of its 5 ballot items in their SEC Form N-PX filings, covering 496 separate fund positions. On the most widely held item on that ballot — APPROVAL, ON AN ADVISORY (NON-BINDING) BASIS, OF THE COMPENSATION OF THE COMPANY'S NAMED… — FOR was 99.0% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: GoodRx Holdings, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 18, 2026.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from GoodRx Holdings, Inc.’s 10-Q dated March 31, 2026. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.

GoodRx Holdings, Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).

Cite this page

Proxy Votes Now, “GoodRx Holdings (GDRX) 2026 Annual Meeting: Shareholder Vote Results”, https://proxyvotesnow.com/company/goodrx-holdings-inc/2026 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.